• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

南非青年在开发艾滋病毒预防植入物方面的观点。

Perspectives of South African youth in the development of an implant for HIV prevention.

机构信息

Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.

RTI International, Women's Global Health Imperative, San Francisco, California, USA.

出版信息

J Int AIDS Soc. 2018 Aug;21(8):e25170. doi: 10.1002/jia2.25170.

DOI:10.1002/jia2.25170
PMID:30152004
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6111144/
Abstract

INTRODUCTION

Implants are a new dosage form in development for HIV pre-exposure prophylaxis (PrEP) with potential for high adherence given that they are provider-administered and are intended for long-acting protection. Integrating end-user preference into early stage product development may further overcome challenges with future product uptake and adherence. Hence, we sought to optimize the design of a PrEP implant in early-stage development by gathering opinions about implant attributes from potential end-users in South Africa.

METHODS

We conducted 14 focus group discussions (FGDs) with young women and men aged 18 to 24 in Cape Town and Soshanguve, South Africa, inviting participants into discussion as co-designers. FGDs were homogenous by gender and previous implant experience. During FGDs, we showed prototype devices and followed a semi-structured guide with questions on history of contraceptive implant use, preferences for physical characteristics of an implant, implant biodegradability, insertion process, participant-driven ideas for implant design, and social adoption considerations. FGDs were facilitated in English, isiXhosa, Tswana, isiZulu, or Tsonga, audio-recorded, transcribed into English, and qualitatively coded and analysed.

RESULTS

In this qualitative sample of 105 youth (68 women and 37 men), 58 participants were from Soshanguve and 47 from Cape Town, and 23% had previously used contraceptive implants. Participants expressed preferences for several implant design features; specifically, longer duration (≥6 months) was more important to most participants than the size or number of devices implanted. A majority preferred a flexible versus stiff implant to minimize palpability, thereby increasing discreetness and comfort. Nearly all participants favoured a biodegradable implant to avoid removal and thus reduce clinic visits. Concerns about the implant centred on its possible side effects and the "plastic" look of the prototype displayed for demonstration.

CONCLUSIONS

This study offers preliminary insights into an implant for HIV prevention that provides long-lasting protection may be well received among young South Africans. Additionally, flexibility, discreetness, and biodegradability may increase acceptability of the implant. Such end-user feedback is being incorporated into current implant designs in the hope of creating an effective long-acting PrEP product that is likely to achieve high uptake and adherence in target populations.

摘要

简介

植入物是一种新的开发中的 HIV 暴露前预防(PrEP)剂型,由于其由提供者管理,旨在提供长效保护,因此具有高依从性的潜力。将最终用户的偏好纳入早期产品开发中,可能会进一步克服未来产品采用和依从性方面的挑战。因此,我们试图通过从南非的潜在最终用户那里收集有关植入物属性的意见,来优化早期开发中的 PrEP 植入物的设计。

方法

我们在南非开普敦和索沙古夫的 18 至 24 岁的年轻女性和男性中进行了 14 次焦点小组讨论(FGD),邀请参与者作为共同设计者参与讨论。FGD 按照性别和以前的植入物使用经验进行分组。在 FGD 中,我们展示了原型设备,并遵循半结构化指南进行讨论,问题包括避孕植入物使用史、对植入物物理特性的偏好、植入物的生物降解性、插入过程、参与者驱动的植入物设计理念,以及社会接受度的考虑因素。FGD 以英语、伊西索萨语、茨瓦纳语、祖鲁语或聪加语进行,录音,翻译成英语,然后进行定性编码和分析。

结果

在这个定性样本中,有 105 名青年(68 名女性和 37 名男性),其中 58 名来自索沙古夫,47 名来自开普敦,23%的人以前使用过避孕植入物。参与者对几种植入物设计特征表示出偏好;具体而言,大多数参与者更看重较长的持续时间(≥6 个月),而不是植入的装置的大小或数量。大多数参与者更喜欢柔软的植入物而不是坚硬的植入物,以最大限度地减少触感,从而增加隐蔽性和舒适性。几乎所有参与者都赞成使用可生物降解的植入物,以避免移除,从而减少就诊次数。对植入物的关注集中在其可能的副作用和展示的原型的“塑料”外观上。

结论

这项研究初步探讨了一种可能在南非年轻人中受到欢迎的长效 HIV 预防植入物。此外,灵活性、隐蔽性和生物降解性可能会提高植入物的可接受性。这种最终用户的反馈正在被纳入当前的植入物设计中,希望能创造出一种有效的长效 PrEP 产品,很可能在目标人群中实现高采用率和高依从性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afaa/6111144/784d110fe46d/JIA2-21-e25170-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afaa/6111144/b3d835bee947/JIA2-21-e25170-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afaa/6111144/f140901e7714/JIA2-21-e25170-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afaa/6111144/784d110fe46d/JIA2-21-e25170-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afaa/6111144/b3d835bee947/JIA2-21-e25170-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afaa/6111144/f140901e7714/JIA2-21-e25170-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afaa/6111144/784d110fe46d/JIA2-21-e25170-g003.jpg

相似文献

1
Perspectives of South African youth in the development of an implant for HIV prevention.南非青年在开发艾滋病毒预防植入物方面的观点。
J Int AIDS Soc. 2018 Aug;21(8):e25170. doi: 10.1002/jia2.25170.
2
Design of an Implant for Long-Acting HIV Pre-Exposure Prophylaxis: Input from South African Health Care Providers.长效 HIV 暴露前预防植入物的设计:南非医疗保健提供者的意见。
AIDS Patient Care STDS. 2019 Apr;33(4):157-166. doi: 10.1089/apc.2018.0177.
3
Preferences for long-acting Pre-Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment.南非青年对长效暴露前预防(PrEP)用于 HIV 预防的偏好:一项离散选择实验的结果。
J Int AIDS Soc. 2020 Jun;23(6):e25528. doi: 10.1002/jia2.25528.
4
"Killing two birds with one stone" - a qualitative study on women's perspectives on the dual prevention pill in Johannesburg, South Africa.一石二鸟——南非约翰内斯堡女性对双重预防丸的看法的定性研究。
BMC Womens Health. 2024 Aug 22;24(1):462. doi: 10.1186/s12905-024-03269-8.
5
Long-Acting Injection and Implant Preferences and Trade-Offs for HIV Prevention Among South African Male Youth.长效注射和植入预防南非男青年 HIV 的偏好和权衡。
J Acquir Immune Defic Syndr. 2021 Jul 1;87(3):928-936. doi: 10.1097/QAI.0000000000002670.
6
The Invisible Product: Preferences for Sustained-Release, Long-Acting Pre-exposure Prophylaxis to HIV Among South African Youth.无形的产品:南非青年对长效抗逆转录病毒预防艾滋病病毒持续释放制剂的偏好。
J Acquir Immune Defic Syndr. 2019 Apr 15;80(5):542-550. doi: 10.1097/QAI.0000000000001960.
7
Implants for HIV prevention in young women: Provider perceptions and lessons learned from contraceptive implant provision.用于预防年轻女性感染 HIV 的植入物:从避孕植入物提供中获得的提供者认知和经验教训。
PLoS One. 2022 Jan 13;17(1):e0262043. doi: 10.1371/journal.pone.0262043. eCollection 2022.
8
A qualitative study to identify critical attributes and attribute-levels for a discrete choice experiment on oral pre-exposure prophylaxis (PrEP) delivery among young people in Cape Town and Johannesburg, South Africa.一项定性研究,旨在确定南非开普敦和约翰内斯堡年轻人中口服暴露前预防(PrEP)提供的离散选择实验的关键属性和属性水平。
BMC Health Serv Res. 2021 Jan 6;21(1):17. doi: 10.1186/s12913-020-05942-8.
9
Incorporating end-users' voices into the development of an implant for HIV prevention: a discrete choice experiment in South Africa and Zimbabwe.将最终用户的声音纳入预防 HIV 植入物的开发中:南非和津巴布韦的离散选择实验。
BMC Womens Health. 2023 Feb 10;23(1):58. doi: 10.1186/s12905-023-02181-x.
10
Understanding the Acceptability of Subdermal Implants as a Possible New HIV Prevention Method: Multi-Stage Mixed Methods Study.了解皮下植入作为一种可能的新型艾滋病毒预防方法的可接受性:多阶段混合方法研究。
J Med Internet Res. 2020 Jul 27;22(7):e16904. doi: 10.2196/16904.

引用本文的文献

1
Barriers to and Facilitators of Heterosexual Men's Engagement with the PrEP Care Continuum in Sub-Saharan Africa: A Scoping Review.撒哈拉以南非洲地区异性恋男性参与暴露前预防(PrEP)护理连续过程的障碍与促进因素:一项范围综述
AIDS Behav. 2025 Aug 14. doi: 10.1007/s10461-025-04847-z.
2
User preferences on long-acting pre-exposure prophylaxis for HIV prevention in Eastern and Southern Africa: a scoping review.东非和南部非洲地区用户对长效暴露前预防艾滋病病毒的偏好:一项范围综述
BMC Public Health. 2025 Jul 3;25(1):2361. doi: 10.1186/s12889-025-23529-y.
3
Acceptability of an annual tenofovir alafenamide implant for HIV prevention in South African women: findings from the CAPRISA 018 Phase I clinical trial.

本文引用的文献

1
Uptake and early removals of Implanon NXT in South Africa: Perceptions and attitudes of healthcare workers.南非对依伴侬NXT的接受情况及早期停用情况:医护人员的看法和态度
S Afr Med J. 2017 Oct 1;107(10):822-826. doi: 10.7196/SAMJ.2017.v107i10.12821.
2
User perspectives on Implanon NXT in South Africa: A survey of 12 public-sector facilities.南非用户对依伴侬NXT的看法:对12家公共部门机构的调查
S Afr Med J. 2017 Oct 1;107(10):815-821. doi: 10.7196/SAMJ.2017.v107i10.12833.
3
HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project.
南非女性中用于预防艾滋病的替诺福韦艾拉酚胺年度植入剂的可接受性:CAPRISA 018 I期临床试验结果
J Int AIDS Soc. 2025 Feb;28(2):e26426. doi: 10.1002/jia2.26426.
4
Acceptability of a dapivirine levonorgestrel vaginal ring in two Phase 1 trials (MTN-030/IPM 041 and MTN-044/IPM 053/CCN019): Implications for multipurpose prevention technology development.达匹韦林左炔诺孕酮阴道环在两项1期试验(MTN - 030/IPM 041和MTN - 044/IPM 053/CCN019)中的可接受性:对多用途预防技术开发的启示。
PLoS One. 2025 Jan 14;20(1):e0312957. doi: 10.1371/journal.pone.0312957. eCollection 2025.
5
South African Parents' and Grandparents' Perspectives on the Acceptability of Implant Delivery of Treatment to Young Children with HIV.南非父母和祖父母对向感染艾滋病毒的幼儿提供植入式治疗的可接受性的看法。
AIDS Behav. 2025 Jan;29(1):13-21. doi: 10.1007/s10461-024-04515-8. Epub 2024 Oct 28.
6
Jitegemee (rely on yourself): a multi-phase process of co-creating a personal savings intervention with female sex workers in western Kenya to reduce their HIV risk.吉特盖梅(依靠自己):与肯尼亚西部的性工作女性共同创建个人储蓄干预措施以减少其 HIV 风险的多阶段过程。
BMC Public Health. 2024 Oct 18;24(1):2873. doi: 10.1186/s12889-024-20348-5.
7
HIV Prevention Product Acceptability and Preference Among Women in Sub-Saharan Africa to Inform Novel Biomedical Options in Development: A Systematic Review.撒哈拉以南非洲地区女性对艾滋病预防产品的可接受性和偏好,为新型生物医学研发选项提供信息:一项系统综述
AIDS Behav. 2025 Jan;29(1):257-293. doi: 10.1007/s10461-024-04529-2. Epub 2024 Oct 18.
8
Prevention method preferences and factors influencing hypothetical choice among women in South Africa: a survey exploring opportunities for a multipurpose prevention technology implant.南非女性的预防方法偏好及影响假设选择的因素:一项探索多用途预防技术植入机会的调查
Front Reprod Health. 2024 Jun 25;6:1368889. doi: 10.3389/frph.2024.1368889. eCollection 2024.
9
Assessing Preferences for Long-Acting Injectable Pre-Exposure Prophylaxis Among Young Adult Sexual Minority Men and Transgender Women.评估青年成年性少数男性和跨性别女性对长效注射型暴露前预防措施的偏好。
Acad Pediatr. 2024 Sep-Oct;24(7):1110-1115. doi: 10.1016/j.acap.2024.04.005. Epub 2024 Apr 15.
10
End-user research into understanding perceptions of and reactions to a microarray patch (MAP) for contraception among women in Ghana, Kenya and Uganda.针对加纳、肯尼亚和乌干达女性对避孕用微阵列贴片(MAP)的认知及反应的终端用户研究。
Front Reprod Health. 2024 Mar 7;6:1351692. doi: 10.3389/frph.2024.1351692. eCollection 2024.
南非女性性工作者中的HIV暴露前预防和早期抗逆转录病毒治疗:一项前瞻性观察示范项目的结果
PLoS Med. 2017 Nov 21;14(11):e1002444. doi: 10.1371/journal.pmed.1002444. eCollection 2017 Nov.
4
End-Users' Product Preference Across Three Multipurpose Prevention Technology Delivery Forms: Baseline Results from Young Women in Kenya and South Africa.三种多用途预防技术传递形式下的最终用户产品偏好:肯尼亚和南非年轻女性的基线结果。
AIDS Behav. 2018 Jan;22(1):133-145. doi: 10.1007/s10461-017-1911-6.
5
Divergent Preferences for HIV Prevention: A Discrete Choice Experiment for Multipurpose HIV Prevention Products in South Africa.对 HIV 预防措施的不同偏好:南非多用途 HIV 预防产品的离散选择实验。
Med Decis Making. 2018 Jan;38(1):120-133. doi: 10.1177/0272989X17729376. Epub 2017 Sep 1.
6
Long acting systemic HIV pre-exposure prophylaxis: an examination of the field.长效全身 HIV 暴露前预防:该领域的考察。
Drug Deliv Transl Res. 2017 Dec;7(6):805-816. doi: 10.1007/s13346-017-0391-6.
7
Misreporting of Product Adherence in the MTN-003/VOICE Trial for HIV Prevention in Africa: Participants' Explanations for Dishonesty.非洲MTN - 003/VOICE艾滋病预防试验中产品依从性的误报:参与者对不诚实行为的解释
AIDS Behav. 2017 Feb;21(2):481-491. doi: 10.1007/s10461-016-1609-1.
8
Preferences for ARV-based HIV prevention methods among men and women, adolescent girls and female sex workers in Gauteng Province, South Africa: a protocol for a discrete choice experiment.南非豪登省男性、女性、少女及女性性工作者对基于抗逆转录病毒药物的艾滋病毒预防方法的偏好:一项离散选择实验方案
BMJ Open. 2016 Jun 27;6(6):e010682. doi: 10.1136/bmjopen-2015-010682.
9
Stated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) study.在VOICE-D(MTN-003D)研究中,女性对HIV暴露前预防的既定产品配方偏好。
J Int AIDS Soc. 2016 May 30;19(1):20875. doi: 10.7448/IAS.19.1.20875. eCollection 2016.
10
A Tunable, Biodegradable, Thin-Film Polymer Device as a Long-Acting Implant Delivering Tenofovir Alafenamide Fumarate for HIV Pre-exposure Prophylaxis.一种可调节、可生物降解的薄膜聚合物装置,作为长效植入剂用于递送富马酸替诺福韦艾拉酚胺以进行HIV暴露前预防。
Pharm Res. 2016 Jul;33(7):1649-56. doi: 10.1007/s11095-016-1904-6. Epub 2016 Mar 14.